Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
-
Vanguard Food Announces Corporate Rebrand to Verdexa Holdings
-
Baker Hughes Secures Major LNG Technology Order for Venture Global’s CP2 LNG Expansion
-
Marex Group Limited to announce second quarter 2026 results on August 12, 2026
-
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
-
Fury Resumes Activities at Eau Claire
-
Findsio Launches Advanced Reverse Image Lookup Tool for Online Identity Verification
-
Global Times: Bilingual narrator bridges cultural divides, shares early days of CPC with the world
-
AECOM selected to design New Lisbon Airport
-
Stunning Second-Weekend Momentum for THE ODYSSEY Drives the Most Successful IMAX Run in AMC Theatres History
-
Ameren Missouri plans new energy center to deliver long-term value and around-the-clock power
-
The Coca-Cola Company Announces Significant Progress in Restoring fairlife Operations Following Technology Disruption
-
GCT Semiconductor Holding, Inc. to Give Business Update and Announce Second Quarter 2026 Financial Results on August 10, 2026
-
Christopher Nolan’s The Odyssey Continues its Journey in IMAX with Record-Breaking $48 Million Second Weekend
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
UNLOCKD Expands International Growth Strategy With Appointment of Ancient Extracts UK Co-Founder to Its Board of Directors
-
Strauss Group Announces Timing of Second Quarter 2026 Earnings Release and Webcast
-
InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study
-
InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study
-
Genesco Announces schuh Leadership Transition
-
Novo Nordisk A/S - share repurchase programme
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
Bank of Hawai‘i Corporation Second Quarter 2026 Financial Results
-
Target Hospitality Announces New $660 Million Credit Facility, Significantly Expanding Liquidity and Lowering Cost of Capital to Support Strategic Growth
-
Teladoc Health Canada Achieves Accreditation Canada Primer Award, Advancing Quality Standards for Virtual and Hybrid Care in Canada
-
W&T Offshore Announces Timing of Second Quarter 2026 Earnings Release and Conference Call
-
Ferguson to Issue Second Quarter Results And Host Conference Call on August 10, 2026
-
SPX Announces Appointment of New Board Member
-
Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GAMMA COMMUNICATIONS PLC - Ordinary Shares
-
Black Book Expands Vendor-Agnostic Healthcare Supply Chain Technology Benchmark to 36 Categories for AHRMM26
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC Energy PLC - Ordinary Shares
-
Why Your Freezer Door Is Hard to Open After Closing
-
Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026
-
Beyond the Signal: KuCoin Marks Its 9th Anniversary With a Multi-Track Competition and Total Rewards of Up to 650,000 USDT
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Goldgroup Announces Leadership Transition as Company Advances Next Phase of Growth
-
EON Resources Inc. Announces Results of Engineering and Petrophysics Study in Its South Justis Unit
-
GT Resources Receives 10-Year, Class III Exploration Permit for the Canalask Copper - Nickel Project, Yukon
-
Perfect Corp. Reports Unaudited Financial Results for the Three Months and Six Months Ended June 30, 2026
-
Marriott Bonvoy Launches New Destination Discovery Experiences Across China with Acclaimed Author Ma Boyong
-
City of Munich selects CGI to advance digital government services and technological sovereignty
-
Oklo Announces Date for Second Quarter 2026 Financial Results and Business Update Call
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
Anta Scaffolding Selected to Support Al Maktoum International Airport Project, Strengthening Local Delivery Through Dubai Office
-
CorVel Corporation to Host Live Earnings Release Webcast
-
iLands launches: A Shared Economic Network Where Autonomous AI Agents and Humans Work, Trade, and Co-evolve
-
PGIM to Acquire Remaining Interest in Deerpath Capital
-
Transactions in connection with share buyback programme
-
Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model
